What Obamacare Did for Patients — and What It Didn’t Fix –

NAJ graphic

The Big Picture –
By Glynn Wilson –

When President Barack Obama signed the Affordable Care Act into law in 2010, the first law ever passed by Congress to REGULATE health care in the United States, the central promise was straightforward. More Americans would have access to health insurance and fewer people would be financially devastated by illness.

On that basic objective, the law accomplished a great deal.

But 16 years later, another transformation has been occurring at the same time.

American health care has become increasingly dominated by large hospital systems, insurance companies, physician groups and private-equity-backed organizations.

So did the Affordable Care Act make American medicine better for patients while leaving — or perhaps helping accelerate — the corporate machinery underneath it?

The answer is complicated.

What the ACA Changed

Before the ACA’s major coverage provisions took effect in 2014, people buying insurance on the individual market could face enormous disadvantages if they had a medical history.

Insurers could refuse coverage or charge substantially more because of preexisting conditions. Benefits could be limited. Some policies offered relatively little protection against catastrophic medical expenses.

The ACA fundamentally changed those rules.

Insurers generally cannot deny coverage or charge people more because they have a preexisting condition. The law also prohibits lifetime dollar limits on essential health benefits and restricts annual limits.

For patients with diabetes, cancer, heart disease or other chronic conditions, that was a revolutionary change.

Before the ACA, getting sick could make it difficult or impossible for some people to obtain affordable individual insurance.

After the ACA, being sick could no longer legally make someone uninsurable in the individual market.

That is one of the law’s most important achievements.

Millions Gained Coverage

The ACA’s insurance marketplaces and Medicaid expansion substantially reduced the number of Americans without insurance.

Research examining the law’s first enrollment period found that ACA-related coverage accounted for a large majority of the decline in the uninsured rate during that period. The effects have continued.

Marketplace enrollment reached a record 24.2 million people in 2025, according to the Commonwealth Fund, with 93 percent of marketplace enrollees relying on premium tax credits. And the broader decline in the uninsured rate has been associated with improved access to care.

The percentage of U.S. adults who said they did not receive health care because of cost fell from 15.9 percent in 2013 to 11.7 percent in 2023. That’s not a small change.

For millions of Americans, the ACA meant that seeing a doctor became financially possible when it previously wasn’t.

Preventive Care Was Another Major Victory

The ACA also changed the economics of prevention.

Most health plans must cover a specified group of preventive services without requiring patients to pay copayments or coinsurance when the services are delivered in-network. These include various screening tests and immunizations.

That’s particularly important in cardiovascular medicine. Preventing a heart attack is vastly preferable to treating one. Detecting high blood pressure, high cholesterol and other risk factors early can save lives and reduce medical costs.

The ACA therefore moved American insurance policy somewhat away from the idea that insurance should primarily pay for catastrophic events and toward the idea that preventive medicine should be part of ordinary health care.

But Insurance Isn’t the Same as Affordable Health Care

This is where the story gets more complicated. Having an insurance card does not necessarily mean a person can easily afford medical care.

A patient may have a $5,000 or $7,000 deductible. There may be substantial copayments and coinsurance. A specialist may not participate in the patient’s network.

A hospital may be technically covered while a particular physician is not. A medication may be subject to a large deductible.

And an insurance company may require prior authorization before approving treatment.

The Commonwealth Fund’s recent analysis found that ACA marketplace plans frequently achieve relatively low premiums by shifting more costs to patients through deductibles and other cost sharing. Silver-plan deductibles often exceed $5,000, while bronze-plan deductibles approach $7,500.

In other words:

The ACA helped make insurance more accessible. It did not necessarily make health care inexpensive. That distinction is crucial.

The Narrow-Network Problem

There is another trade-off. Insurance companies compete partly by keeping premiums down. One way to do that is to negotiate lower payment rates with physicians and hospitals. Another is to construct narrower networks. That can leave patients with fewer choices.

The Commonwealth Fund has noted that ACA marketplace plans can use narrower provider networks to reduce premiums. So a patient may receive a heavily subsidized insurance plan but discover that the cardiologist they want isn’t in the network.

That creates a strange situation. The government helps a person buy insurance. The insurance company offers a relatively inexpensive plan.

But the patient may have difficulty finding the particular doctor they want.

And Here Corporate Medicine Enters the Picture

The ACA didn’t create corporate medicine. Hospital consolidation, physician employment by hospitals, managed care and insurance-industry consolidation were already underway.

But the ACA entered an environment in which health care was increasingly being organized around large networks and integrated systems.

There are logical reasons for that. Large organizations can negotiate with insurance companies. They can purchase expensive equipment. They can operate electronic medical-record systems. They can employ specialists. They can provide 24-hour emergency coverage. They can spread administrative costs across thousands of patients.

And the ACA’s emphasis on measuring quality, coordinating care and managing populations fits more naturally into large organizations than into a physician practicing alone.

This doesn’t make the ACA responsible for corporate medicine. But it helps explain why insurance reform and health-care consolidation can occur simultaneously.

The Patient’s New Relationship With the System

Consider what happens to a hypothetical heart patient.

Under the old system, the patient might have had difficulty obtaining insurance because of a preexisting cardiac condition. Under the ACA, that patient can obtain coverage. That’s a major victory.

But the patient may then enter a large health-care system. The cardiologist may be an employee rather than an independent physician.

The appointment may be scheduled through a centralized call center. The doctor may have a productivity target. The insurance company may require authorization for certain procedures.

The electronic medical record may generate reminders and protocols. The hospital may measure the physician’s performance using dozens of metrics.

The patient has insurance. The patient has access to sophisticated medicine.

But the patient may still feel like a number moving through a machine.

That is the paradox.

The Good Side of the Corporate System

It would be wrong to romanticize the old system. Independent medicine had serious weaknesses. Some physicians operated inefficiently.

Medical records could be terrible. Small practices couldn’t afford sophisticated equipment. Coordination between doctors was often poor.

Patients could fall through the cracks.

Large health systems can solve some of those problems.

A modern cardiovascular center can bring cardiologists, cardiac surgeons, emergency physicians, nurses, imaging specialists and rehabilitation professionals together. That is enormously valuable.

A patient suffering a heart attack doesn’t need a romanticized version of the old country doctor. They need an emergency department, a catheterization laboratory, an experienced interventional cardiologist and a team that knows what to do immediately.

Scale can save lives.

The Bad Side

But scale can also produce bureaucracy. The larger the organization becomes, the more layers of management may exist between the patient and the physician.

The doctor becomes an employee. The hospital becomes a corporation. The insurer becomes a gatekeeper.

The patient becomes an enrollee.

The physician’s work becomes measurable in productivity units.

And medical decisions increasingly occur inside a complicated economic structure.

This is where the assembly-line analogy becomes useful.

A factory wants consistency.

Medicine sometimes requires consistency.

But a patient isn’t a standardized product.

Two people with the same diagnosis may have radically different circumstances, risks, priorities and responses to treatment.

The danger is not standardization itself.

The danger is allowing the economics of standardization to overwhelm individual clinical judgment.

The ACA’s Great Achievement — and Its Great Limitation

The ACA deserves credit for several fundamental changes. Patients with preexisting conditions gained important protections. Millions of people gained insurance. Preventive services became more accessible.

Lifetime limits on essential health benefits were eliminated. Low- and moderate-income people gained access to subsidized coverage.

Medicaid was expanded in participating states.

Those are substantial accomplishments.

But the law did not create universal health care.

It did not eliminate deductibles, eliminate medical debt or eliminate narrow provider networks.

It did not eliminate insurance companies’ role as gatekeepers. And it did not stop the consolidation of physicians and hospitals into larger corporate organizations.

In that sense, the ACA was primarily insurance reform rather than a complete transformation of the American health-care delivery system.

What Patients Should Ask Now

For patients, particularly people dealing with serious conditions such as heart disease, the lesson is that having insurance is only the beginning.

Patients should ask:

Is my physician actually in my network?

What is my deductible?

What is my maximum annual out-of-pocket exposure?

Which hospitals can I use?

What happens if I need emergency treatment outside my network?

Does the system have the specialists I may eventually need?

How quickly can I see a specialist?

Who makes the decision if my insurance company denies treatment?

And perhaps the most important question:

Does my doctor have enough time to listen to me?

The Future of American Medicine

The ACA didn’t cause every problem in American medicine. Nor did it solve every problem.

What it did was create a larger safety net around a fundamentally complicated and increasingly corporate health-care system.

That’s why the debate over American medicine cannot simply be reduced to Obamacare versus repeal. The more difficult question is what comes next.

Can America preserve the ACA’s most important protections while making actual medical care more affordable?

Can patients have broad access to doctors without paying enormous premiums?

Can hospitals remain financially viable without turning medicine into a production line?

Can physicians work inside large systems without becoming primarily production workers?

Can technology and artificial intelligence improve efficiency without eliminating the human relationship between doctor and patient?

And can America build a system in which the financial incentives serve the patient rather than forcing the patient to serve the financial incentives?

Those questions reach far beyond the Affordable Care Act. They go to the heart of what American medicine is becoming.

The ACA made an important promise:

If you get sick, you shouldn’t become uninsurable.

The next generation of health-care reform has to answer a different question:

If you are insured, can you actually afford to get well?

__
Part I – Facts Matter: The State of Health Care in America

Part II: When Medicine Starts to Look Like a Factory

Part IV – Trump’s Changes to American Health Care

Part V – Nine Billion People on a Warming Planet: Humanity’s Next Great Test

___
If you support truth in reporting with no paywall, and fearless writing with no popup ads or sponsored content, consider making a contribution today with GoFundMe or Patreon or PayPal.